Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lipocine (LPCN) Revenue (2018 - 2025)

Lipocine's Revenue history spans 8 years, with the latest figure at $114574.0 for Q3 2025.

  • For Q3 2025, Revenue changed N/A year-over-year to $114574.0; the TTM value through Sep 2025 reached $4.3 million, down 42.29%, while the annual FY2024 figure was $11.2 million, 292.8% up from the prior year.
  • Revenue reached $114574.0 in Q3 2025 per LPCN's latest filing, down from $622849.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $16.1 million in Q4 2021 to a low of -$216188.0 in Q4 2023.
  • Average Revenue over 5 years is $2.3 million, with a median of $104219.0 recorded in 2025.
  • Peak YoY movement for Revenue: surged 19926.5% in 2021, then tumbled 98.77% in 2025.
  • A 5-year view of Revenue shows it stood at $16.1 million in 2021, then tumbled by 96.89% to $500000.0 in 2022, then plummeted by 143.24% to -$216188.0 in 2023, then skyrocketed by 1714.99% to $3.5 million in 2024, then crashed by 96.72% to $114574.0 in 2025.
  • Per Business Quant, the three most recent readings for LPCN's Revenue are $114574.0 (Q3 2025), $622849.0 (Q2 2025), and $93864.0 (Q1 2025).